High positive sentinel node identification rate by EORTC melanoma group protocol
Alexander C. J. van Akkooi(The University of Sydney), Alexander M.M. Eggermont(University Medical Center Utrecht), Cornelis Verhoef(Erasmus MC Cancer Institute), Johannes H. W. de Wilt(Radboud University Nijmegen), A.N. van Geel(Erasmus MC), Wilfried J. Graveland(Erasmus MC Cancer Institute), Mike Kliffen(Maasstad Ziekenhuis)
Cited by 102
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k